Site icon pharmaceutical daily

Cell Encapsulation Markets 2019-2030: Focus on Therapeutics and Technologies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell
Encapsulation: Focus on Therapeutics and Technologies, 2019-2030”

report has been added to ResearchAndMarkets.com’s
offering.

The ‘Cell Encapsulation: Focus on Therapeutics and Technologies,
2019-2030’ report features an extensive study of the current market
landscape and the future potential of encapsulated cell therapies and
affiliated technologies. It is worth mentioning that the study also
provides insights on therapy products wherein other active drug
substances have been encapsulated within living cells.

One of the key objectives of the report was to understand the primary
growth drivers and estimate the future size of the market. Based on
likely licensing deal structures and agreements that are expected to be
signed in the foreseen future, we have provided an informed estimate on
the likely evolution of the market for the period 2019-2030.

In addition, we have provided information on (potential) sales-based
revenues generated by encapsulated cell therapies that are currently in
late stages of development for the treatment of different chronic
disorders, based on parameters, such as target consumer segments, likely
adoption rates, and expected pricing.

The report features likely distribution of the current and forecasted
opportunity across [A] different therapeutic areas (eye disorders,
metabolic disorders, neurological disorders, and oncological disorders),
[B] target disease indications (ataxia telangiectasia, breast cancer,
diabetes, glaucoma, head and neck cancer, macular telangiectasia,
pancreatic cancer, Parkinson’s disease, and retinitis pigmentosa), [C]
type of encapsulation material used (alginate-based microcapsules,
cellulose hydrogels, medical-grade plastics, and red blood cells), and
[D] key geographical regions (North America, Europe and Asia Pacific).

To account for the uncertainties associated with the development of
novel therapeutic products and to add robustness to our model, we have
provided three forecast scenarios, portraying the conservative, base and
optimistic tracks of the market’s evolution.

Amongst other elements, the report features:

For more information about this report visit https://www.researchandmarkets.com/r/rmefs5

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biomaterials

Exit mobile version